EUDA Health Holdings (EUDA) said late Monday it has entered into preliminary discussions with Guangdong Cell Biotech to form a joint venture.
The potential collaboration between EUDA and Guangdong, a stem cell-focused biotech company, is aimed at biotechnology and consumer health sector innovations, the company said.
The two companies have not yet entered into a legally binding agreement, EUDA said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.